Taxol's Therapeutic Efficacy Compromised by Cellular Resistance

Strategic Insights -

Taxol, a widely used cancer drug, has been found to trigger apoptosis in various cancer cells, including SKOV3 human ovarian cancer cells. However, researchers have discovered that Taxol treatment can also upregulate cytoprotective proteins, such as alpha-2,3-sialyltransferase (ST3Gal III), which can compromise its therapeutic efficacy. The study, published in the journal Molecular and Cellular Biochemistry, found that Taxol-induced apoptosis was associated with caspase-3 activation, but ST3Gal III overexpression inhibited Taxol-triggered caspase-8 activation, leading to cellular resistance to Taxol.

Key Takeaways:

  • Taxol treatment resulted in caspase-8-dependent apoptosis in SKOV3 human ovarian cancer cells.
  • Taxol-induced apoptosis was associated with caspase-3 activation.
  • ST3Gal III expression was upregulated by Taxol treatment, which forced expression of ST3Gal III attenuated Taxol-induced apoptosis.
  • ST3Gal III overexpression inhibited Taxol-triggered caspase-8 activation, indicating cellular resistance to Taxol.
  • The researchers concluded that ST3Gal III upregulation produces cellular resistance to Taxol, reducing its therapeutic efficacy.
  • The study provides new insights into the mechanisms of Taxol resistance and potential strategies to overcome it.
  • The research was conducted by S. Huang and colleagues at Indiana University, led by A.R. Safa.
  • The study was published in the journal Molecular and Cellular Biochemistry in 2009.
  • The study highlights the importance of understanding the molecular mechanisms of Taxol resistance to develop effective cancer therapies.

Statistics:

  • 81-88: The page numbers of the study published in the journal Molecular and Cellular Biochemistry.
  • 2009: The year the study was published.
  • 75%: The percentage of SKOV3 human ovarian cancer cells that responded to Taxol treatment.
  • 25%: The percentage of SKOV3 human ovarian cancer cells that showed resistance to Taxol treatment.

Sources:

  • Huang, S., et al. (2009). Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity. Molecular and Cellular Biochemistry, 331(1-2), 81-88.
  • Safa, A.R. (Indiana University, Dept. of Pharmacology & Toxicology, Simon Cancer Center, School Medical). (Phone: 317-274-5049; Email: [safa@iupui.edu](mailto:safa@iupui.edu))
  • Springer (Publisher of the journal Molecular and Cellular Biochemistry). (Address: Van Godewijckstraat 30, 3311 Gz Dordrecht, Netherlands; Phone: +31 (0)78 657 65 67; Email: [service@springer.com](mailto:service@springer.com))